Faculty profile

Peter Jüni

ResearcherCentre for Urban Health SolutionsUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Peter Jüni

Researcher

Centre for Urban Health Solutions

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
3 publications in the last five years, latest in 2023.
Principal investigator on 10 research grants (10 CIHR), most recently in 2022.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Adaptive Platform Trial Covid-19 Nirmatrelvir Out-Patient Sars-Cov-2 Therapeutics Perioperative Medicine Postoperative Complications

Latest papers

Utility of SARS-CoV-2 Genomic Sequencing for Understanding Transmission and School Outbreaks.
The Pediatric infectious disease journal · 2023
A Web-Based Health Application to Translate Nutrition Therapy for Cardiovascular Risk Reduction in Primary Care (PortfolioDiet.app): Quality Improvement and Usability Testing Study
JMIR Human Factors · 2022
Cardiovascular meta-analyses: fool's gold or gold for fools?
European heart journal · 2022

All 14 publications

Latest funding

Efficacy of antioxidant therapy in mild to moderate SARS-CoV-2 infection: An experimental arm of the CanTreatCOVID adaptive platform trial
CIHR · 2023 · Co-investigator
$100,000
Guidelines for reporting trial protocols and completed trials modified due to the COVID-19 Pandemic and other extenuating circumstances: The CONSERVE 2021 Statement
CIHR · 2023 · Co-investigator
$25,000
Guidelines for reporting trial protocols and completed trials modified due to the COVID-19 Pandemic and other extenuating circumstances: The CONSERVE 2021 Statement
CIHR · 2023 · Co-investigator
$25,000

All 37 grants and awards

14 publications.

Utility of SARS-CoV-2 Genomic Sequencing for Understanding Transmission and School Outbreaks.

Campigotto A, Chris A, Orkin J, Lau L, Marshall C, Bitnun A, Buchan SA, MacDonald L, Thampi N, McCready J, Juni P, Parekh RS, Science M

The Pediatric infectious disease journal2023

DOI: 10.1097/inf.0000000000003834 PMID: 36795555

A Web-Based Health Application to Translate Nutrition Therapy for Cardiovascular Risk Reduction in Primary Care (PortfolioDiet.app): Quality Improvement and Usability Testing Study

Kavanagh ME, Chiavaroli L, Glenn AJ, Heijmans G, Grant SM, Chow C-M, Josse RG, Malik VS, Watson W, Lofters A

JMIR Human Factors202214 citations

DOI: 10.2196/34704

Cardiovascular meta-analyses: fool's gold or gold for fools?

Biondi-Zoccai G, Windecker S, Juni P, Bhatt DL

European heart journal2022

DOI: 10.1093/eurheartj/ehac312 PMID: 35714033

Effects of the PCSK9 antibody alirocumab on coronary atherosclerosis in patients with acute myocardial infarction: a serial, multivessel, intravascular ultrasound, near-infrared spectroscopy and optical coherence tomography imaging study-Rationale and design of the PACMAN-AMI trial.

Zanchin C, Koskinas KC, Ueki Y, Losdat S, Häner JD, Bär S, Otsuka T, Inderkum A, Jensen MRJ, Lonborg J, Fahrni G, Ondracek AS, Daemen J, van Geuns RJ, Iglesias JF, Matter CM, Spirk D, Juni P, Mach F, Heg D, Engstrom T, Lang I, Windecker S, Räber L

American heart journal2021

DOI: 10.1016/j.ahj.2021.04.006 PMID: 33951415

The association of preoperative blood markers with postoperative readmissions following arthroplasty.

Khoshbin A, Hoit G, Nowak LL, Daud A, Steiner M, Juni P, Ravi B, Atrey A

Bone & joint open2021

DOI: 10.1302/2633-1462.26.bjo-2021-0020 PMID: 34139875

Adherence at 2 years with distribution of essential medicines at no charge: The CLEAN Meds randomized clinical trial.

Persaud N, Bedard M, Boozary A, Glazier RH, Gomes T, Hwang SW, Juni P, Law MR, Mamdani M, Manns B, Martin D, Morgan SG, Oh P, Pinto AD, Shah BR, Sullivan F, Umali N, Thorpe KE, Tu K, Laupacis A, Carefully seLected and Easily Accessible at No Charge Medications (CLEAN Meds) study team

PLoS medicine2021

DOI: 10.1371/journal.pmed.1003590 PMID: 34019540

Predicting 2-year all-cause mortality after contemporary PCI: Updating the logistic clinical SYNTAX score.

Chichareon P, van Klaveren D, Modolo R, Kogame N, Takahashi K, Chang CC, Tomaniak M, Yuan J, Xie L, Song Y, Qiao S, Yang Y, Guan C, Zurakowski A, van Geuns RJ, Sabate M, Ong PJ, Wykrzykowska JJ, Piek JJ, Garg S, Hamm C, Steg G, Vranckx P, Valgimigli M, Windecker S, Juni P, Onuma Y, Steyerberg E, Xu B, Serruys PW

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions2021

DOI: 10.1002/ccd.29490 PMID: 33539048

Corrigendum to "Mixed methods feasibility study for the surviving opioid overdose with naloxone education and resuscitation (SOONER) trial" [Resuscitation Plus 6 (2021) 100131].

Orkin AM, Charles M, Norris K, Thomas R, Chapman L, Wright A, Campbell DM, Handford C, Klaiman M, Hopkins S, Shahin R, Thorpe K, Juni P, Parsons J, Sellen K, Goso N, Hunt R, Leece P, Morrison LJ, Stergiopoulos V, Turner S, Strike C

Resuscitation plus2021

DOI: 10.1016/j.resplu.2021.100158 PMID: 34553182

Association of Pulse Pressure With Clinical Outcomes in Patients Under Different Antiplatelet Strategies After Percutaneous Coronary Intervention: Analysis of GLOBAL LEADERS.

de Faria AP, Modolo R, Chichareon P, Chang CC, Kogame N, Tomaniak M, Takahashi K, Rademaker-Havinga T, Wykrzykowska J, de Winter RJ, Ferreira RC, Sousa A, Lemos PA, Garg S, Hamm C, Juni P, Vranckx P, Valgimigli M, Windecker S, Onuma Y, Steg PG, Serruys PW

The Canadian journal of cardiology2020

DOI: 10.1016/j.cjca.2019.10.015 PMID: 32139280

Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY).

Leonardi S, Franzone A, Piccolo R, McFadden E, Vranckx P, Serruys P, Benit E, Liebetrau C, Janssens L, Ferrario M, Zurakowski A, van Geuns RJ, Dominici M, Huber K, Slagboom T, Buszman P, Bolognese L, Tumscitz C, Bryniarski K, Aminian A, Vrolix M, Petrov I, Garg S, Naber C, Prokopczuk J, Hamm C, Steg G, Heg D, Juni P, Windecker S, Valgimigli M

BMJ open2019

DOI: 10.1136/bmjopen-2018-026053 PMID: 30852547

Something wrong or missing on this profile? Suggest a correction

Peter Jüni

Research

Latest papers

Latest funding

Utility of SARS-CoV-2 Genomic Sequencing for Understanding Transmission and School Outbreaks.

A Web-Based Health Application to Translate Nutrition Therapy for Cardiovascular Risk Reduction in Primary Care (PortfolioDiet.app): Quality Improvement and Usability Testing Study

Cardiovascular meta-analyses: fool's gold or gold for fools?

Effects of the PCSK9 antibody alirocumab on coronary atherosclerosis in patients with acute myocardial infarction: a serial, multivessel, intravascular ultrasound, near-infrared spectroscopy and optical coherence tomography imaging study-Rationale and design of the PACMAN-AMI trial.

The association of preoperative blood markers with postoperative readmissions following arthroplasty.

Adherence at 2 years with distribution of essential medicines at no charge: The CLEAN Meds randomized clinical trial.

Predicting 2-year all-cause mortality after contemporary PCI: Updating the logistic clinical SYNTAX score.

Corrigendum to "Mixed methods feasibility study for the surviving opioid overdose with naloxone education and resuscitation (SOONER) trial" [Resuscitation Plus 6 (2021) 100131].

Association of Pulse Pressure With Clinical Outcomes in Patients Under Different Antiplatelet Strategies After Percutaneous Coronary Intervention: Analysis of GLOBAL LEADERS.

Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY).

Frequent collaborators

Muhammad Mamdani

Andreas Laupacis

Hwee Teoh

Bobby Yanagawa

Marie-Annick Clavel

Janet Parsons

Amy Wright

Pamela Leece

Aaron Campigotto

Rita Shahin

Paul Oh

Danielle Martin

Laura Chiavaroli

Allison Chris

Candice Holmes

Fan Victor Chu

Braden Manns

Vicky Stergiopoulos

Pierre Voisine

Karen Tu

Patrick Mathieu

Carol Strike

Shaun Hopkins

Vicky Stergiopoulos

Kevin Thorpe

Duminda Wijeysundera

Aisha Lofters

Frank Sullivan

Aisha Lofters

Joel Katz

Hance Clarke

Ian Gilron

Curtis Handford

Tara Gomes